Russell Investments Group, Ltd. Neu Base Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$4.63 - $7.34 $100,248 - $158,925	-21,652 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$6.92 - $9.25 $89,544 - $119,695	-12,940 Reduced 37.41%	21,652 $151,000
Q3 2020 Nov 09, 2020	BUY	$7.25 - $9.71 $205,552 - $275,297	28,352 Added 454.36%	34,592 $262,000
Q2 2020 Aug 05, 2020	BUY	$6.69 - $11.51 $41,745 - $71,822	6,240 New	6,240 $54,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.